Advertisement

FortuneIndia

Quick Links :

Fortune 500 India
40 Under 40
Most Powerful Women
Budget 2024
India's Richest
The Next 500
Best B-Schools
Opinion
First Edit
Multimedia
Events

Fortune 500 India
40 Under 40
Most Powerful Women
The Next 500
Best B-Schools
All Rankings
Events
Macro
Enterprise
Technology
Reviews
Venture
Investing
Multimedia
Fortune India Exchange
Bystander
Opinion
Infographics
Ideas
Long Reads
People
Buy on Amazon
Polemicist
Annual Subscription

gene therapy

Share

October 2023

Laurus Injects Tech In Pharma

Laurus Injects Tech In Pharma

Under Satyanarayana Chava, the company has entered cutting-edge areas such as gene therapy and rare diseases.

By Joe Mathew

Advertisement

Top Stories

RPSG Group’s Firstsource Solutions acquires UK-based Ascensos

RPSG Group’s Firstsource Solutions acquires UK-based Ascensos

9 out of 10 individual traders faced losses in equity F&O in FY22-FY24

9 out of 10 individual traders faced losses in equity F&O in FY22-FY24

‘This is India's moment; seize the opportunity’: Nvidia CEO Jensen Huang

‘This is India's moment; seize the opportunity’: Nvidia CEO Jensen Huang

US sanctions against China to benefit Indian solar exports

US sanctions against China to benefit Indian solar exports

SpiceJet's ₹3,000 cr QIP oversubscribed; shares surge 10%

SpiceJet's ₹3,000 cr QIP oversubscribed; shares surge 10%

Advertisement

Advertisement

Top Stories

RPSG Group’s Firstsource Solutions acquires UK-based Ascensos

RPSG Group’s Firstsource Solutions acquires UK-based Ascensos

9 out of 10 individual traders faced losses in equity F&O in FY22-FY24

9 out of 10 individual traders faced losses in equity F&O in FY22-FY24

‘This is India's moment; seize the opportunity’: Nvidia CEO Jensen Huang

‘This is India's moment; seize the opportunity’: Nvidia CEO Jensen Huang

US sanctions against China to benefit Indian solar exports

US sanctions against China to benefit Indian solar exports

SpiceJet's ₹3,000 cr QIP oversubscribed; shares surge 10%

SpiceJet's ₹3,000 cr QIP oversubscribed; shares surge 10%

Contact Us
Vision & Core Values
Terms of Use
Privacy & Cookie Policy

Powered by Quintype